Extracellular Vesicle-Derived mir-148a-3p Promotes Plasmablast Differentiation in Bullous Pemphigoid via BACH2 Repression and mTOR Activation
Listen to this summary
This study aims to elucidate the molecular mechanisms behind plasmablast differentiation in bullous pemphigoid (BP), an autoimmune blistering disease. The authors found that extracellular vesicle-derived miR-148a-3p enhances plasmablast differentiation by repressing BACH2 and activating the mTOR signaling pathway, suggesting a novel regulatory mechanism in BP pathogenesis and highlighting miR-148a-3p as a potential diagnostic and therapeutic target.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The Journal of investigative dermatology
View all →More in Dermatology
View all →Nov 19, 2026 · Lancet (London, England)
Spontaneous coronary artery dissection: implications for women's health, clinical care, and future research.
Nov 19, 2026 · Lancet (London, England)
Reproductive health in women in Britain from 2010 to 2024: findings from repeated, cross-sectional National Surveys of Sexual Attitudes and Lifestyles (Natsal).
Nov 19, 2026 · Lancet (London, England)
Seasonal mass vaccination with R21/Matrix-M against malaria in The Gambia and Burkina Faso: an open-label, cluster-randomised, controlled trial.
Nov 19, 2026 · The New England journal of medicine
Assessing Multiple Treatment Regimens for Tuberculosis.
Nov 18, 2026 · The New England journal of medicine
Acute Respiratory Distress Syndrome.
Nov 17, 2026 · Lancet (London, England)
Natural ligand-based CAR T-cell therapy targeting BCMA and TACI for relapsed or refractory multiple myeloma (TriPRIL): a non-randomised, phase 1, first-in-human trial.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


